Pioglitazone reduces smooth muscle cell density of rat carotid arterial intima induced by balloon catheterization

Hormone and Metabolic Research

Volumn 29, Issue 9, 1997, Pages 444-449

  Ishibashi, N ^a   Takahashi, K ^b   Tominaga, M ^b   Soto, Y ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Balloon catheterization; Insulin resistance; Intimal thickening; Pioglitazone; Smooth muscle cell; Wistar fatty rat

Indexed keywords

ALPHA ACTIN; PIOGLITAZONE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON CATHETER; CELL DENSITY; COMMON CAROTID ARTERY; CONTROLLED STUDY; FEMORAL ARTERY; IMMUNOHISTOCHEMISTRY; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALIA;

EID: 0030699447     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979074     Document Type: Article

References (30)

1. Hofmann, C. A.J. R. Colca: New oral thiazolidinedione antidiabetic agents act as insulin sensitizers. Diabetes Care 15: 1075-1078 (1992)
2. Colca,]. R., C. F. Dailey. B.j. Palazuk. R. M. Hillman, D. M. Dihn, C. W. Melchior, C. H. Spilman: Pioglitazone hydrochloride inhibits cholesterol absorption and lowers plasma cholesterol concentrations in cholesterol-fed rats. Diabetes 40:1669-1674 (1991)
3. Hofmann, C, K. LorenzJ. R. Colca: Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone. Endocrinology 129: 1915-1925 (1991)
4. Ikeda, H., S. Taketomi, Y. Sugiyama, Y. Shimura, T. Sohda. K. Meguro, T. Fujita: Effect of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Arzneim Forsch Drug Res 40:156-162(1990)
5. KemnitzJ. W., D. F. Elson, E. B. Roecker, S. T. Baum, R. N. Bergman, M. D. Meglasson: Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure in obese, insulin-resistant rhesus monkeys. Diabetes 43: 204-211 (1994)
6. Sofia, A. K., T. G. Kurowski.J. R. Colca, N. B. Ruderman: Lipid abnormalities in tissues of the KKA mouse: effects of pioglitazone on malonyl-CoAand diacylglycerol. AmJ Physiol 267: E95-E101 (1994)
7. Iwanishi, M., M. Kogayashi: Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat-fed rats. Metabolism 42:1017-1021(1993)
8. Kobayashi, M., M. Iwanishi, K. Egawa, Y. Shigeta: Pioglitazone increases insulin sensitivity by activating insulin receptor kinase. Diabetes 41:476-483 (1992)
9. Zhang, B., D. Szalkowski, E. Diaz, N. Hayes, R. Smith,]. Berger: Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinediones-derived antidiabetic agent in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes. J Biol Chem 269: 25735-25741 (1994)
10. Agewall, S., J. Wikstrand, M. Suurkula, L Tengborn, B. Fagertberg: Carotid artery wall morphology, haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for atherosclerotic disease. Blood Coagul Fibrinolysis 5: 895 - 904 (1994)
11. Bonner, G.: Hyperinsulinemia, insulin resistance, and hypertension. JCardiovasc Pharmacol 24(Suppl. 2): S39-S49 (1994)
12. Ciugliano, D., R. Acampora, F. D'Onojrio: Medical hypothesis: cardiovascular complications of diabetes mellitus-from glucose to insulin and back. Diabete Metab 20: 445-453 (1994)
13. Reaven, G. M.: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595 -1607 (1988)
14. Stem, M. P.: Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes44: 369-374 (1995)
15. Stout, R. W.: Insulin and atheroma. Diabetes Care 13: 631-654 (1990)
16. Ikeda, H., A. Shino, T. Matsuo, H. Iwatsuka, Z. Suzuoki: A new genetically obese-hyperglycemic rat (Wistar Fatty). Diabetes 30: 1045-1050(1981)
17. Hsu, S. M., L Raine, H. Fanger: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedures.] Histochem Cytochem 29: 577-580 (1981)
18. is Fischer-Dzoga, K., R. M.Jones, D. Vesselinovitch, R. W. Wissler: Ultrastructural and immunohistochemical studies of primary cultures of aortic medial cells. Exp Mol Pathol 18:162 -176 (1973)
19. Kanzaki, T., M. SMnomiya, M. Ueda, N. Morisaki, Y. Saito, S. Yoshida: Enhanced arterial intimai thickening after balloon catheter injury in diabetic animals accompanied by PDGF -receptor overexpression of aortic media. EurJ Clin Invest 24: 377-381 (1994)
20. Lehman, J. M., L B. Moore, T. A. Smith-Oliver, W. 0. Wilkinson, W. 0. Wilson, T. M. Wilson, S. A. Kliewer: An antidiabetic thiazolinedione is a high affinity ligand for peroxisome proliferator-activated receptor y (PPAR y). J Biol Chem 270:12953 -12956 ( 1995)
21. Sandouk, T., D. Rede, C. Hofmann: Antidiabetic agent pioglitazone enhances adipocytes differentiation of 3T3-F422A cells. Am J Physiol 264: C1600-C1608 (1993)
22. Law,]. M., W. P. Meehan, X. P. Xi, K. Graf, D. A. Wuthrich. W. Coats. D. Faxon, W. A. Hsueh: Troglitazone inhibits vascular smooth muscle cell growth and intimai hyperplasia.J Clin Invest 98: 1897-1905 (1995)
23. Ross, R.: The pathogenesis of atherosclerosis - An update. N EngJ Med 314: 488-500 (1986)
24. Tipping, P. G., W. W. Hancock: Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol 142: 1721 -1728 (1993)
25. Li, H., M. W. Freeman, P. Libby: Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines.J Clin Invest 95:122-133 (1995)
26. Ross, R.: The pathogenesis of atherosclerosis - a perspective for the 1990s. Nature 362: 801 -809 (1993)
27. Hofmann. C, K. Lorenz, S. S. Braithwaite.J. R. Colca, B.J. Palazuk, G. S. Hotamisligil, B. M. Spiegelman: Altered gene expression for tumor necrosis factor-a and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134: 264-270 (1994)
28. Dubey, R. K.. H. Y. Zhang, S. R. Reddy, M. A. Boegehold, T. A. Kotchen: Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats. Am J Physiol 256: R726R732(1993)
29. Nadler,]., S. Scott: Evidence that pioglitazone increases intracellular free magnesium concentration in freshly isolated rat adipocytes. Biochem Biophys Res Commun 202: 416-421 (1994)
30. Zhang. F..J. R. Sowers,J. L Ram, P. R. Standley,]. D. Peuler: Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension 24:170-175(1994)